Log in to search using one of your social media accounts:

 

Dr Reddy's gets EIR for Vizag plant, but inspection not closed
It, however, said the US Food and Drug Administration has not closed the inspection and the manufacturing site's status remains unchanged. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 21, 2017 Category: Pharmaceuticals Source Type: news

Goya Voluntary Recall of Adobo Because of Possible Health Risk
Goya de Puerto Rico is recalling 28 ounces Adobo with Cumin Seasoning and 28 ounces Adobo with Pepper Seasoning because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune system. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 21, 2017 Category: Food Science Source Type: news

Why LivaNova Is Unloading Its CRM Business
LivaNova, formerly known as Sorin Group, has decided to get out of the cardiac rhythm management (CRM) business and shift more focus to its areas of strength.  The London-based company plans to sell its CRM business to Shanghai-based MicroPort for $190 million in cash. The business, which makes high-voltage defibrillators, cardiac resynchronization therapy devices and low-voltage pacemakers, generated about $249 million in net sales in the fiscal year 2016. The business has roughly 900 employees with operations chiefly in Clamart, France; Saluggia, Italy; and Santo Domingo, Dominican Republic. The company said in Sept...
Source: MDDI - November 20, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Medical Device Business Source Type: news

Seeking food safety information about that turkey? Call the hotline!
With Thanksgiving nearly upon us, I want to share the food and nutrition resources provided by our partners in the federal government, such as the United States Department of Agriculture (USDA), Food and Drug Administration (FDA), and Centers for Disease Control (CDC). Within these resources, you’ll find food and nutrition resources, such as Thanksgiving infographics, recipes, food fact sheets, food labeling resources, and important food safety information. All of these resources are organized into an online guide, which was created by Kay Deeney in our Pacific Southwest Region. One of the tools I’ve found most...
Source: The Cornflower - November 20, 2017 Category: Databases & Libraries Authors: Elizabeth Kiscaden Tags: Consumer Health Training Source Type: news

French Oncologists Upgrade Mesothelioma Standard of Care
Oncologists throughout France have joined the U.S.-based National Comprehensive Cancer Network (NCCN) in upgrading their recommended standard-of-care treatment regimen for unresectable pleural mesothelioma. Both groups have added bevacizumab (Avastin) to the traditional cisplatin and pemetrexed chemotherapy combination, expecting to see longer patient survival. “This is a major advancement for the care of mesothelioma patients,” Dr. Gerard Zalcman, head of thoracic oncology at Bichat-Claude Bernard Hospital, told Asbestos.com. “Clearly, this drug can change the natural history of this tumor.” Bevaci...
Source: Asbestos and Mesothelioma News - November 20, 2017 Category: Environmental Health Authors: Daniel King Tags: American Society of Clinical Oncology Avastin bevacizumab Bichat-Claude Bernard Hospital French Cooperative Thoracic Intergroup Gerard Zalcman National Comprehensive Cancer Network nintedanib Ofev pleural mesothelioma chemotherapy Source Type: news

United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2017 -- (Healthcare Sales & Marketing Network) -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivi... Biopharmaceuticals, FDA, Licensing United Therapeutics, Adcirca, tadalafil, Duchenne muscular dystrophy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2017 Category: Pharmaceuticals Source Type: news

Health Tip: Infant Medication Advice For New Moms
-- A new mom has enough stress on her hands without worrying about giving medication to her newborn. The U.S. Food and Drug Administration suggests: Get your doctor's advice before giving medication to your baby. Store any medication out of your... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 20, 2017 Category: General Medicine Source Type: news

Protecting its interests: FDA attacks CBD supplements to protect Big Pharma's opioid profits
(Natural News) Big Pharma is working overtime to restrict consumer access to cannabidiol, or CBD, a non-psychoactive component of cannabis sativa (marijuana) that’s been shown to help relieve pain, muscle spasms, and other ailments. Using the U.S. Food and Drug Administration (FDA) as authoritative cover, the industry is quietly leading the charge to ban CBD... (Source: NaturalNews.com)
Source: NaturalNews.com - November 19, 2017 Category: Consumer Health News Source Type: news

Expanded Voluntary Recall for Casa Sanchez Foods " Real Guacamole " and to also Include “Spicy Guacamole” Because of Possible Health Risk
Casa Sanchez Foods of Hayward, CA, is voluntarily recalling all " Real Guacamole " and “Spicy Guacamole” products out of an abundance of caution in keeping with the company’s commitment to protect the public health. The recall was necessitated by positive test results for Listeria monocytogenes on two packages out of many samples collected for the U. S. Food and Drug Administrat ion random sample testing program. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 18, 2017 Category: Food Science Source Type: news

Casa Sanchez Foods Extiende El Retiro Voluntario Del " Real Guacamole " Para Incluir “Spicy Guacamole” Del Mercado Por Causa De Posible Riesgo Para La Salud
Casa Sanchez Foods de Hayward, California, est á retirando todo su " Real Guacamole " y “Spicy Guacamole” del mercado, por precaución de acuerdo con el compromiso de la compañía para proteger la salud pública. La retirada fue necesaria por los resultados de pruebas positivas para Listeria monocytogenes en dos paquetes de muchas muestras recogidas para el programa de pruebas de muestras aleatorias de la Administración de Drogas y Alimentos de EE. UU. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 18, 2017 Category: Food Science Source Type: news

Expanded Voluntary Recall for Casa Sanchez Foods " Real Guacamole " and to also Include “ Spicy Guacamole ” Because of Possible Health Risk
Casa Sanchez Foods of Hayward, CA, is voluntarily recalling all " Real Guacamole " and “ Spicy Guacamole ” products out of an abundance of caution in keeping with the company ’ s commitment to protect the public health. The recall was necessitated by positive test results for Listeria monocytogenes on two packages out of many samples collected for the U. S. Food and Drug Administration random sample testing program. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 18, 2017 Category: Food Science Source Type: news

Casa Sanchez Foods Extiende El Retiro Voluntario Del " Real Guacamole " Para Incluir “ Spicy Guacamole ” Del Mercado Por Causa De Posible Riesgo Para La Salud
Casa Sanchez Foods de Hayward, California, est á retirando todo su " Real Guacamole " y “ Spicy Guacamole ” del mercado, por precauci ó n de acuerdo con el compromiso de la compa ñ í a para proteger la salud p ú blica. La retirada fue necesaria por los resultados de pruebas positivas para Listeria monocytogenes en dos paquetes de muchas muestras recogidas para el programa de pruebas de muestras aleatorias de la Administraci ó n de Drogas y Alimentos de EE. UU. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 18, 2017 Category: Food Science Source Type: news

Health Ranger: EPA, FDA building their own private armies with body armor and military weapons
(Natural News) Natural News founder/editor Mike Adams said in a recent podcast that two government agencies that shouldn’t be — the Environmental Protection Agency and the Food and Drug Administration —  are now arming up with military-style equipment such as body armor, spending tens of millions of dollars on such gear over the last few... (Source: NaturalNews.com)
Source: NaturalNews.com - November 17, 2017 Category: Consumer Health News Source Type: news

FDA approves first telehealth option to program cochlear implants remotely
FDA approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 17, 2017 Category: American Health Source Type: news

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls
Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts by the agency to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 17, 2017 Category: American Health Source Type: news

FDA approves Roche ’s Gazyva for previously untreated advanced follicular lymphoma
Roche announced today that the US Food and Drug Administration (FDA) approved Gazyva ® (obinutuzumab) in combination with chemotherapy, followed by Gazyva alone in those who responded, for people with previously untreated advanced follicular lymphoma (stage II bulky, III or IV). The approval is based on results from the phase III GALLIUM study, which showed superior progression-fre e survival (PFS) for patients who received this Gazyva-based regimen compared with those who received a Rituxan® (rituximab)-based regimen as an initial (first-line) therapy. Follicular lymphoma, the most common slow-growing (indolent) f...
Source: Roche Media News - November 17, 2017 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Gazyva for previously untreated advanced follicular lymphoma
Roche announced today that the US Food and Drug Administration (FDA) approved Gazyva ® (obinutuzumab) in combination with chemotherapy, followed by Gazyva alone in those who responded, for people with previously untreated advanced follicular lymphoma (stage II bulky, III or IV). The approval is based on results from the phase III GALLIUM study, which showed superior progression-fre e survival (PFS) for patients who received this Gazyva-based regimen compared with those who received a Rituxan® (rituximab)-based regimen as an initial (first-line) therapy. Follicular lymphoma, the most common slow-growing (indolent) f...
Source: Roche Investor Update - November 17, 2017 Category: Pharmaceuticals Source Type: news

F.D.A. Speeds Review of Gene Therapies, Vowing to Target Rogue Clinics
The agency plans to speed approval of treatments to get them to the market faster, signaling the quickened pace of advancements in this field. (Source: NYT Health)
Source: NYT Health - November 17, 2017 Category: Consumer Health News Authors: SHEILA KAPLAN and DENISE GRADY Tags: Stem Cells Genetic Engineering Immunotherapy Food and Drug Administration Source Type: news

Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets
For Immediate Release – PEAPACK, NJ, November 16, 2017 - Greenstone LLC, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone initiated this recall because product from these lots has the pote ntial to be super potent or sub potent. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

Medical POLICE STATE: FDA approves "Big Brother" digital sensor that tracks your compliance with psychiatric medications
(Natural News) The U.S. Food and Drug Administration (FDA) has officially granted its approval for a newfangled tracking device that pharmaceutical companies can now legally manufacture into drug pills in order to monitor whether or not patients are taking all of their prescriptions. The technology is being specifically touted as a solution to the problem... (Source: NaturalNews.com)
Source: NaturalNews.com - November 16, 2017 Category: Consumer Health News Source Type: news

FDA expands approval for Pfizer cancer drug Sutent
(Reuters) - The U.S. Food and Drug Administration on Thursday approved the use of Pfizer Inc's cancer drug Sutent to help prevent kidney cancer from returning following surgical removal of a kidney. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Lipari Foods, LLC. Issues Voluntary Product Recall of Specific Dark Chocolate Products Due to Undeclared Milk Allergen
Lipari Foods, LLC has issued a voluntary recall of specific dark chocolate products packaged by sister company JLM due to an undeclared milk allergen. People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume these products. The products are safe for consumption by those who do not have an allergy or severe sensitivity to milk. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

FDA expands approval of Sutent to reduce the risk of kidney cancer returning
FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: American Health Source Type: news

FDA Approves Sutent (sunitinib malate) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
November 16, 2017 -- The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 16, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 16, 2017 -- The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 16, 2017 Category: Drugs & Pharmacology Source Type: news

FDA backs Roche's Gazyva in first-line follicular lymphoma
ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated follicular lymphoma, bolstering the Swiss drugmaker's efforts to strengthen its portfolio of blood cancer medicines. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Roche hemophilia drug wins FDA nod, with a warning
ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's Hemlibra, a new medicine for hemophilia A that the Swiss drugmaker is counting on to help to offset eroding sales of older medicines going off patent. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves new treatment to prevent bleeding in certain patients with hemophilia A
FDA approves new treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: American Health Source Type: news

FDA approves Roche hemophilia drug Hemlibra
ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's Hemlibra for hemophilia suffers, a new medicine the Swiss drugmaker is counting on to help it offset eroding sales of its older medicines that have begun going off patent. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves Roche ’s Hemlibra (emicizumab-kxwh) for haemophilia A with inhibitors
Roche today announced that the US Food and Drug Administration (FDA) has approved Hemlibra ® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with haemophilia A with factor VIII inhibitors. (Source: Roche Media News)
Source: Roche Media News - November 16, 2017 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Hemlibra (emicizumab-kxwh) for haemophilia A with inhibitors
Roche today announced that the US Food and Drug Administration (FDA) has approved Hemlibra ® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with haemophilia A with factor VIII inhibitors. (Source: Roche Investor Update)
Source: Roche Investor Update - November 16, 2017 Category: Pharmaceuticals Source Type: news

Giant/Martin ’s Alerts Customers to Voluntary Recall of Store Brand Frozen Whole Kernel Sweet Corn
GIANT Food Stores, LLC and MARTIN ’S Food Markets announced it removed from sale GIANT/MARTIN’S Brand Frozen Whole Kernel Sweet Corn due to potential Listeria monocytogenes contamination. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

Giant/Martin ’ s Alerts Customers to Voluntary Recall of Store Brand Frozen Whole Kernel Sweet Corn
GIANT Food Stores, LLC and MARTIN ’ S Food Markets announced it removed from sale GIANT/MARTIN ’ S Brand Frozen Whole Kernel Sweet Corn due to potential Listeria monocytogenes contamination. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

Stop & Shop Alerts Customers to Voluntary Recall of Store Brand Frozen Whole Kernel Sweet Corn
The Stop& Shop Supermarket Company LLC announced it removed from sale Stop& Shop Brand Frozen Whole Kernel Sweet Corn due to potential Listeria monocytogenes contamination. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

Giant Food Alerts Customers to Voluntary Recall of Store Brand Frozen Whole Kernel Sweet Corn
Giant Food, LLC announced it removed from sale Giant Brand Frozen Whole Kernel Sweet Corn due to potential Listeria monocytogenes contamination. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
SILVER SPRING, Md., Nov. 16, 2017 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hem... Biopharmaceuticals, FDA Genentech, Hemlibra, emicizumab, hemophilia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2017 Category: Pharmaceuticals Source Type: news

FDA Announces Comprehensive Regenerative Medicine Policy Framework
Framework aims to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy SILVER SPRING, Md., Nov. 16, 2017 -- (Healthcare Sales & Marketing Network) -- Today the U.S. Food and Drug Administration an... Regenerative Medicine, FDA U.S. Food and Drug Administration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2017 Category: Pharmaceuticals Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA ’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health
Commissioner statement on FDA ’s comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: American Health Source Type: news

Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA ’ s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health
Commissioner statement on FDA ’ s comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: American Health Source Type: news

FDA announces comprehensive regenerative medicine policy framework
to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: American Health Source Type: news

FDA Seeks to Speed Development of'Regenerated' Organs for Medical Use
THURSDAY, Nov. 16, 2017 -- Using stem cells to grow new heart tissue, and even whole organs, used to be the stuff of science fiction. But the field of " regenerative medicine " is a reality now -- and the U.S. Food and Drug Administration has its eye... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2017 Category: General Medicine Source Type: news

New Hemophilia A Treatment, Hemlibra (Emicizumab-kxwh), Stems Bleeding Episodes
THURSDAY, Nov. 16, 2017 -- Hemlibra (emicizumab-kxwh) has been approved by the U.S. Food and Drug Administration to prevent or reduce the number of bleeding episodes among certain people with hemophilia A. The injected drug was approved for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2017 Category: General Medicine Source Type: news

FDA Warns About Stem Cell Therapies
Stem cells have been called everything from cure-alls to miracle treatments. But don't believe the hype. The U.S. Food and Drug Administration is concerned that some patients may be vulnerable to stem cell treatments that are illegal and potentially harmful. Here's what to know before you consider stem cell treatment. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - November 16, 2017 Category: Consumer Health News Source Type: news

Pfizer receives FDA approval for SUTENT ® (sunitinib malate) as first and only adjuvant treatment for adult patients at high risk of recurrent renal cell carcinoma
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy (surgical removal of the cancerous kidney). (Source: World Pharma News)
Source: World Pharma News - November 16, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Children still being prescribed codeine, despite warnings
Codeine prescriptions for children who have had their tonsils and adenoids removed have decreased since the Food and Drug Administration began requiring a black box warning on the products four years ago, according to a new report from the American Academy of Pediatrics. However, some children continue to be prescribed codeine, and other opioid prescriptions for children have continued to rise since then. (Source: CNN.com - Health)
Source: CNN.com - Health - November 16, 2017 Category: Consumer Health News Source Type: news

Casa Sanchez Foods Recalls " Real Guacamole " Because Of Possible Health Risk
Casa Sanchez Foods of Hayward, CA, is recalling its 9-ounce containers of " Real Guacamole " because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

Yorgo ’s Foods Inc Is Recalling All Flavored and Unflavored Food Products (Hommus; Tahini Sauces; Yogurt Dip, Salads, Tzatziki, Grape Leaves; Taboule) Due to Possible Health Risk
Yorgo ’s Foods Inc. of Manchester NH, a family-owned company, started in 1993, is recalling all Greek-style food products it manufactures, out of an abundance of caution, as they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal in fections in pregnant women, young children, frail or elderly people, those with weakened immune systems and in unborn fetuses. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages ...
Source: Food and Drug Administration - November 16, 2017 Category: Food Science Source Type: news

FDA Grants Marketing Authorization of the First Device for Use in Helping to Reduce the Symptoms of Opioid Withdrawal
November 15, 2017 -- Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal. “Given the scope of the epidemic of opioid addiction, we... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2017 Category: Pharmaceuticals Source Type: news

Kratom Association Hits Back at'Unsubstantiated' FDA Advisory Kratom Association Hits Back at'Unsubstantiated' FDA Advisory
The American Kratom Association has petitioned the US Food and Drug Administration to'review and correct'the agency's November 14 public health advisory on the dangers of kratom.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII
November 15, 2017 -- The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 15, 2017 Category: Drugs & Pharmacology Source Type: news